2 months Biogen Sinks. Why A Surprise Boost From Its Alzheimer’s Drug Wasn’t Enough. Investor's Business Daily
Biogen stock dipped Wednesday despite an unexpected boost from its new Alzheimer’s drug, Leqembi, and an earnings guidance hike.
The post Biogen Sinks. Why A Surprise Boost From Its Alzheimer's Drug Wasn't Enough. appeared first on Investor&#…
Biogen (BIIB) · Business · Earnings
X